Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures, 56933-56934 [2022-20131]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
All comments submitted in response
to this notice are a matter of public
record. USPTO will include or
summarize each comment in the request
to OMB to approve this information
collection. Before including an address,
phone number, email address, or other
personally identifiable information (PII)
in a comment, be aware that the entire
comment—including PII—may be made
publicly available at any time. While
you may ask in your comment to
withhold PII from public view, USPTO
cannot guarantee that it will be able to
do so.
Justin Isaac,
Acting Information Collections Officer, Office
of the Chief Adminstrative Officer, United
States Patent and Trademark Office.
[FR Doc. 2022–20132 Filed 9–15–22; 8:45 am]
BILLING CODE 3510–30–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Information Collection
Activities; Submission to the Office of
Management and Budget (OMB) for
Review and Approval; Comment
Request; Requirements for Patent
Applications Containing Nucleotide
Sequence and/or Amino Acid
Sequence Disclosures
The United States Patent and
Trademark Office (USPTO) will submit
the following information collection
request to the Office of Management and
Budget (OMB) for review and clearance
in accordance with the Paperwork
Reduction Act of 1995, on or after the
date of publication of this notice. The
USPTO invites comment on this
information collection renewal, which
helps the USPTO assess the impact of
its information collection requirements
and minimize the public’s reporting
burden. Public comments were
previously requested via the Federal
Register on June 7, 2022 during a 60-day
comment period. This notice allows for
an additional 30 days for public
comments.
Agency: United States Patent and
Trademark Office, Department of
Commerce.
Title: Requirements for Patent
Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence
Disclosures.
OMB Control Number: 0651–0024.
Needs and Uses: Patent applications
that contain nucleotide and/or amino
VerDate Sep<11>2014
16:43 Sep 15, 2022
Jkt 256001
acid sequence disclosures falling within
the definitions of 37 CFR 1.821(a) (for
applications filed on or before June 30,
2022) or 37 CFR 1.831 (for applications
filed on or after July 1, 2022) must
include, as a separate part of the
disclosure, a copy of the sequence
listing in accordance with the
requirements in 37 CFR 1.821–1.825 or
37 CFR 1.831–1.835, respectively.
Applicants may submit sequence
listings for both U.S. and international
biotechnology patent applications.
Submissions of sequence listings in
international applications are governed
by Patent Cooperation Treaty (PCT)
Rules 5.2 and 13ter, as well as the PCT
Administrative Instructions, Annex C.
The USPTO uses applicants’ sequence
listings during the examination process
to determine the patentability of the
claimed invention. The USPTO also
uses sequence listings for pre-grant
publication of patent applications and
publication of issued patents. Sequence
listings are publicly searchable after
publication of the pre-grant application
or issued patent.
This information collection covers the
submission of sequence listing
information itself. Information
pertaining to the initial filing of U.S.
patent applications is collected under
OMB Control Number 0651–0032 and
information pertaining to the initial
filing of international applications is
collected under OMB Control Number
0651–0021.
Sequence listings in applications filed
on or before June 30, 2022 may be
submitted via the USPTO patent
electronic filing system as an ASCII text
file or as a Portable Document Format
(PDF) file. For U.S. applications filed on
or before June 30, 2022, 37 CFR 1.821(c)
permits all modes of submission: paper,
read-only optical disc, or electronic
filing via the USPTO patent electronic
filing system. Sequence listings for
international applications may only be
submitted on paper or through the
USPTO patent electronic filing system.
Sequence listings that are too large to be
filed electronically through the USPTO
patent electronic filing system may be
submitted on read-only optical disc.
This information collection also
accounts for the requirement under 37
CFR 1.821(e)(1) or 1.821(e)(2) that a
copy of the sequence listing submitted
pursuant to 37 CFR 1.821(c)(2) or (c)(3)
must also be submitted in computer
readable form (CRF) in accordance with
37 CFR 1.824. Under 37 CFR 1.821(e)(1)
or 1.821(e)(2), applicants who submit
their sequence listings on paper or as a
PDF via the USPTO patent electronic
filing system must submit a copy of the
sequence listing in CRF with a
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
56933
statement indicating that the CRF copy
of the sequence listing is identical to the
paper or PDF copy provided under 37
CFR 1.821(c)(3) or 1.821(c)(2),
respectively. Applicants may submit the
CRF copy of the sequence listing to the
USPTO via the USPTO patent electronic
filing system, or on read-only optical
disc or other acceptable media as
provided in 37 CFR 1.824. If a new
application is filed via the USPTO
patent electronic filing system with an
ASCII text file sequence listing that
complies with the requirements of 37
CFR 1.824(a)(1)–(5) and (b), and the
applicant has not filed a sequence
listing on paper or as a PDF file, no
separate text file is required. Therefore,
no associated statement regarding both
copies being identical would be
required. Similarly, if a new application
is filed with an ASCII text file sequence
listing on read-only optical disc that
complies with the requirements of 37
CFR 1.824(a)(1)–(5) and 37 CFR 1.52(e),
the single read-only optical disc is the
CRF, and no additional submission is
required.
Sequence listings in applications filed
on or after July 1, 2022 must be
submitted in XML format per 37 CFR
1.831, which was recently implemented
to achieve alignment with World
Intellectual Property Office Standard
ST.26 (WIPO Standard ST.26) (Standard
for Presentation of Nucleotide and
Amino Acid Sequence Listings Using
eXtensible Markup Language (XML) in
Patent Applications To Implement
WIPO Standard ST.26; Incorporation by
Reference, 87 FR 30806, 5/20/22,
effective July 1, 2022). These
submissions may be made electronically
via the USPTO patent electronic filing
system as an XML file not exceeding
100MB without file compression, or as
an XML file on a read-only optical disc
in accordance with 37 CFR 1.834(b)–(c).
One item, Request for Transfer of a
Computer Readable Form under 37 CFR
1.821(e), has been removed from this
information collection. This item is no
longer part of this information
collection’s process per a recent
rulemaking (Electronic Submission of a
Sequence Listing, a Large Table, or a
Computer Program Listing Appendix in
Patent Applications; 86 FR 57035, 10/
14/2021, effective November 15, 2021).
Form Number(s): None.
Type of Review: Extension and
revision of a currently approved
information collection.
Affected Public: Private sector;
individuals or households.
Respondent’s Obligation: Required to
obtain or retain benefits.
Frequency: On occasion.
E:\FR\FM\16SEN1.SGM
16SEN1
56934
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
Estimated Number of Annual
Respondents: 9,550 respondents.
Estimated Number of Annual
Responses: 28,550 responses.
Estimated Time per Response: The
USPTO estimates that the responses in
this information collection will take the
public approximately 6 hours to
complete. This includes the time to
gather the necessary information, create
the document, and submit the
completed request to the USPTO.
Estimated Total Annual Respondent
Burden Hours: 171,300 hours.
Estimated Total Annual Respondent
Non-Hourly Cost Burden: $1,483,936.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view
Department of Commerce, USPTO
information collections currently under
review by OMB.
Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number 0651–0024.
Further information can be obtained
by:
• Email: InformationCollection@
uspto.gov. Include ‘‘0651–0024
information request’’ in the subject line
of the message.
• Mail: Justin Isaac, Office of the
Chief Administrative Officer, United
States Patent and Trademark Office,
P.O. Box 1450, Alexandria, VA 22313–
1450.
Justin Isaac,
Acting Information Collections Officer, Office
of the Chief Administrative Officer, United
States Patent and Trademark Office.
[FR Doc. 2022–20131 Filed 9–15–22; 8:45 am]
BILLING CODE 3510–16–P
COMMITTEE FOR PURCHASE FROM
PEOPLE WHO ARE BLIND OR
SEVERELY DISABLED
khammond on DSKJM1Z7X2PROD with NOTICES
Procurement List; Additions
Committee for Purchase From
People Who Are Blind or Severely
Disabled.
ACTION: Additions to the Procurement
List.
AGENCY:
This action adds product(s)
and service(s) to the Procurement List
that will be furnished by nonprofit
SUMMARY:
VerDate Sep<11>2014
16:43 Sep 15, 2022
Jkt 256001
agencies employing persons who are
blind or have other severe disabilities.
DATES: Date added to and deleted from
the Procurement List: October 16, 2022.
ADDRESSES: Committee for Purchase
From People Who Are Blind or Severely
Disabled, 355 E Street SW, Washington,
DC 20024.
FOR FURTHER INFORMATION CONTACT:
Michael R. Jurkowski, Telephone: (703)
785–6404, or email CMTEFedReg@
AbilityOne.gov.
SUPPLEMENTARY INFORMATION:
Additions
On 6/10/2022, 6/24/2022, and 7/15/
2022, the Committee for Purchase From
People Who Are Blind or Severely
Disabled published notice of proposed
additions to the Procurement List. This
notice is published pursuant to 41
U.S.C. 8503 (a)(2) and 41 CFR 51–2.3.
After consideration of the material
presented to it concerning capability of
qualified nonprofit agencies to provide
the product(s) and service(s) and impact
of the additions on the current or most
recent contractors, the Committee has
determined that the product(s) and
service(s) listed below are suitable for
procurement by the Federal Government
under 41 U.S.C. 8501–8506 and 41 CFR
51–2.4.
Regulatory Flexibility Act Certification
I certify that the following action will
not have a significant impact on a
substantial number of small entities.
The major factors considered for this
certification were:
1. The action will not result in any
additional reporting, recordkeeping or
other compliance requirements for small
entities other than the small
organizations that will furnish the
product(s) and service(s) to the
Government.
2. The action will result in
authorizing small entities to furnish the
product(s) and service(s) to the
Government.
3. There are no known regulatory
alternatives which would accomplish
the objectives of the Javits-WagnerO’Day Act (41 U.S.C. 8501–8506) in
connection with the product(s) and
service(s) proposed for addition to the
Procurement List.
End of Certification
Accordingly, the following product(s)
and service(s) are added to the
Procurement List:
Product(s)
NSN(s)—Product Name(s): 6930–01–692–
1671—Set, Army Combat Fitness
Equipment (ACFT)
Designated Source of Supply: Envision, Inc.,
PO 00000
Frm 00009
Fmt 4703
Sfmt 4703
Wichita, KS
Mandatory For: 100% of the requirement of
the U.S. Army
Contracting Activity: DEFENSE LOGISTICS
AGENCY, DLA TROOP SUPPORT C&E
(L&M PV)
Distribution: C-List
The Committee finds good cause to
dispense with the 30-day delay in the
effective date normally required by the
Administrative Procedure Act. See 5 U.S.C.
553(d). This addition to the Committee’s
Procurement List is effectuated due to
funding for the Defense Logistics Agency
Troop Support contract. The Federal
customer contacted and has worked
diligently with the AbilityOne Program to
fulfill this service need under the AbilityOne
Program. To avoid performance disruption,
and the possibility that the Defense Logistics
Agency Troop Support will refer its business
elsewhere, this addition must be effective on
September 30, 2022, ensuring timely
execution for a October 1, 2022, start date
while still allowing 14 days for comment.
The Committee published a notice of
proposed Procurement List addition in the
Federal Register on June 10, 2022 and did
not receive any comments from any
interested persons, including from the
incumbent contractor. This addition will not
create a public hardship and has limited
effect on the public at large, but, rather, will
create new jobs for other affected parties—
people with significant disabilities in the
AbilityOne program who otherwise face
challenges locating employment. Moreover,
this addition will enable Federal customer
operations to continue without interruption.
Service(s)
Service Type: Facilities Support Services
Mandatory for: US Navy, Naval Sea Systems
Command, Southwest Regional
Maintenance Center, Naval Base San
Diego, Naval Base Coronado (North
Island), and Naval Base Point Loma, San
Diego, CA
Designated Source of Supply: Professional
Contract Services, Inc., Austin, TX
Contracting Activity: DEPT OF THE NAVY,
SOUTHWEST REGIONAL MAINT
CENTER
The Committee finds good cause to
dispense with the 30-day delay in the
effective date normally required by the
Administrative Procedure Act. See 5 U.S.C.
553(d). This addition to the Committee’s
Procurement List is effectuated because of
the expiration of the U.S. Navy, Facilities
Support Services contract. The Federal
customer contacted and has worked
diligently with the AbilityOne Program to
fulfill this service need under the AbilityOne
Program. To avoid performance disruption,
and the possibility that the U.S. Navy will
refer its business elsewhere, this addition
must be effective on September 30, 2022,
ensuring timely execution for an October 1,
2022, start date while still allowing 14 days
for comment. Pursuant to its own regulation
41 CFR 51–2.4, the Committee determined
that no severe adverse impact exists. The
Committee also published a notice of
proposed Procurement List addition in the
Federal Register on July 15, 2022 and did not
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Pages 56933-56934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20131]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Agency Information Collection Activities; Submission to the
Office of Management and Budget (OMB) for Review and Approval; Comment
Request; Requirements for Patent Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence Disclosures
The United States Patent and Trademark Office (USPTO) will submit
the following information collection request to the Office of
Management and Budget (OMB) for review and clearance in accordance with
the Paperwork Reduction Act of 1995, on or after the date of
publication of this notice. The USPTO invites comment on this
information collection renewal, which helps the USPTO assess the impact
of its information collection requirements and minimize the public's
reporting burden. Public comments were previously requested via the
Federal Register on June 7, 2022 during a 60-day comment period. This
notice allows for an additional 30 days for public comments.
Agency: United States Patent and Trademark Office, Department of
Commerce.
Title: Requirements for Patent Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence Disclosures.
OMB Control Number: 0651-0024.
Needs and Uses: Patent applications that contain nucleotide and/or
amino acid sequence disclosures falling within the definitions of 37
CFR 1.821(a) (for applications filed on or before June 30, 2022) or 37
CFR 1.831 (for applications filed on or after July 1, 2022) must
include, as a separate part of the disclosure, a copy of the sequence
listing in accordance with the requirements in 37 CFR 1.821-1.825 or 37
CFR 1.831-1.835, respectively. Applicants may submit sequence listings
for both U.S. and international biotechnology patent applications.
Submissions of sequence listings in international applications are
governed by Patent Cooperation Treaty (PCT) Rules 5.2 and 13ter, as
well as the PCT Administrative Instructions, Annex C. The USPTO uses
applicants' sequence listings during the examination process to
determine the patentability of the claimed invention. The USPTO also
uses sequence listings for pre-grant publication of patent applications
and publication of issued patents. Sequence listings are publicly
searchable after publication of the pre-grant application or issued
patent.
This information collection covers the submission of sequence
listing information itself. Information pertaining to the initial
filing of U.S. patent applications is collected under OMB Control
Number 0651-0032 and information pertaining to the initial filing of
international applications is collected under OMB Control Number 0651-
0021.
Sequence listings in applications filed on or before June 30, 2022
may be submitted via the USPTO patent electronic filing system as an
ASCII text file or as a Portable Document Format (PDF) file. For U.S.
applications filed on or before June 30, 2022, 37 CFR 1.821(c) permits
all modes of submission: paper, read-only optical disc, or electronic
filing via the USPTO patent electronic filing system. Sequence listings
for international applications may only be submitted on paper or
through the USPTO patent electronic filing system. Sequence listings
that are too large to be filed electronically through the USPTO patent
electronic filing system may be submitted on read-only optical disc.
This information collection also accounts for the requirement under
37 CFR 1.821(e)(1) or 1.821(e)(2) that a copy of the sequence listing
submitted pursuant to 37 CFR 1.821(c)(2) or (c)(3) must also be
submitted in computer readable form (CRF) in accordance with 37 CFR
1.824. Under 37 CFR 1.821(e)(1) or 1.821(e)(2), applicants who submit
their sequence listings on paper or as a PDF via the USPTO patent
electronic filing system must submit a copy of the sequence listing in
CRF with a statement indicating that the CRF copy of the sequence
listing is identical to the paper or PDF copy provided under 37 CFR
1.821(c)(3) or 1.821(c)(2), respectively. Applicants may submit the CRF
copy of the sequence listing to the USPTO via the USPTO patent
electronic filing system, or on read-only optical disc or other
acceptable media as provided in 37 CFR 1.824. If a new application is
filed via the USPTO patent electronic filing system with an ASCII text
file sequence listing that complies with the requirements of 37 CFR
1.824(a)(1)-(5) and (b), and the applicant has not filed a sequence
listing on paper or as a PDF file, no separate text file is required.
Therefore, no associated statement regarding both copies being
identical would be required. Similarly, if a new application is filed
with an ASCII text file sequence listing on read-only optical disc that
complies with the requirements of 37 CFR 1.824(a)(1)-(5) and 37 CFR
1.52(e), the single read-only optical disc is the CRF, and no
additional submission is required.
Sequence listings in applications filed on or after July 1, 2022
must be submitted in XML format per 37 CFR 1.831, which was recently
implemented to achieve alignment with World Intellectual Property
Office Standard ST.26 (WIPO Standard ST.26) (Standard for Presentation
of Nucleotide and Amino Acid Sequence Listings Using eXtensible Markup
Language (XML) in Patent Applications To Implement WIPO Standard ST.26;
Incorporation by Reference, 87 FR 30806, 5/20/22, effective July 1,
2022). These submissions may be made electronically via the USPTO
patent electronic filing system as an XML file not exceeding 100MB
without file compression, or as an XML file on a read-only optical disc
in accordance with 37 CFR 1.834(b)-(c).
One item, Request for Transfer of a Computer Readable Form under 37
CFR 1.821(e), has been removed from this information collection. This
item is no longer part of this information collection's process per a
recent rulemaking (Electronic Submission of a Sequence Listing, a Large
Table, or a Computer Program Listing Appendix in Patent Applications;
86 FR 57035, 10/14/2021, effective November 15, 2021).
Form Number(s): None.
Type of Review: Extension and revision of a currently approved
information collection.
Affected Public: Private sector; individuals or households.
Respondent's Obligation: Required to obtain or retain benefits.
Frequency: On occasion.
[[Page 56934]]
Estimated Number of Annual Respondents: 9,550 respondents.
Estimated Number of Annual Responses: 28,550 responses.
Estimated Time per Response: The USPTO estimates that the responses
in this information collection will take the public approximately 6
hours to complete. This includes the time to gather the necessary
information, create the document, and submit the completed request to
the USPTO.
Estimated Total Annual Respondent Burden Hours: 171,300 hours.
Estimated Total Annual Respondent Non-Hourly Cost Burden:
$1,483,936.
This information collection request may be viewed at
www.reginfo.gov. Follow the instructions to view Department of
Commerce, USPTO information collections currently under review by OMB.
Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice on the following website www.reginfo.gov/public/do/PRAMain.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function and entering either the title of the information collection or
the OMB Control Number 0651-0024.
Further information can be obtained by:
Email: [email protected]. Include ``0651-
0024 information request'' in the subject line of the message.
Mail: Justin Isaac, Office of the Chief Administrative
Officer, United States Patent and Trademark Office, P.O. Box 1450,
Alexandria, VA 22313-1450.
Justin Isaac,
Acting Information Collections Officer, Office of the Chief
Administrative Officer, United States Patent and Trademark Office.
[FR Doc. 2022-20131 Filed 9-15-22; 8:45 am]
BILLING CODE 3510-16-P
